Effect of progressive resistance training on measures of skeletal muscle hypertrophy, muscular strength and health-related quality of life in patients with chronic kidney disease : a systematic review and meta-analysis

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Die Wirkung des progressiven Krafttrainings auf Messwerte der Skelettmuskelhypertrophie, Muskelkraft und gesundheitsbezogenen Lebensqualität bei Patienten mit chronischer Nierenerkrankung : systematischer Review und Metaanalyse
Autor:Cheema, Birinder S.; Chan, Danwin; Fahey, Paul; Atlantis, Evan
Erschienen in:Sports medicine
Veröffentlicht:44 (2014), 8, S. 1125-1138, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Elektronische Ressource (online) Gedruckte Ressource
Sprache:Englisch
ISSN:0112-1642, 1179-2035
DOI:10.1007/s40279-014-0176-8
Schlagworte:
Online Zugang:
Erfassungsnummer:PU201412010710
Quelle:BISp

Abstract des Autors

Background and Objective: Skeletal muscle wasting resulting in reduced muscular strength and health-related quality of life (HR-QOL) is common in chronic kidney disease (CKD) and may be reversed with progressive resistance training (PRT). Therefore, we systematically assessed the effect of PRT on measures of skeletal muscle hypertrophy, muscular strength and HR-QOL in this cohort to inform clinical practice and guidelines. Design: We performed a systematic review and meta-analysis. Inclusion Criteria: We included randomised controlled trials (RCTs) that investigated the independent effect of PRT (>6 weeks) on measures of skeletal muscle hypertrophy [muscle mass or cross-sectional area (CSA)], muscular strength and/or HR-QOL in adults with CKD. Data Extraction and Analysis: The standardised mean difference (SMD) from each study was pooled to produce an overall estimate of effect and associated 95 percent confidence interval (95 percent CI) between treatment and control groups on primary outcomes. Results: Seven RCTs in 271 patients with Stage 3-5 CKD yielded seven studies on muscular strength (N = 249), six studies on total body muscle mass (N = 200) and six studies on HR-QOL (N = 223). PRT significantly improved standardised muscular strength [SMD 1.15 (95 percent CI 0.80-1.49)] and HR-QOL [SMD 0.83 (95 percent CI 0.51-1.16)], but not total body muscle mass [SMD 0.29 (95 percent CI -0.27 to 0.86)] in our primary analysis. However, secondary analysis of six studies showed that PRT induced significant muscle hypertrophy of the lower extremities (leg mass, or mid-thigh or quadriceps CSA) [SMD 0.43 (95 percent CI 0.11-0.76)], a pertinent analysis given that most studies implemented lower-body PRT only. Conclusions: Robust evidence from RCTs indicates that PRT can induce skeletal muscle hypertrophy and increase muscular strength and HR-QOL outcomes in men and women with CKD. Therefore, clinical practice guidelines should be updated to inform clinicians on the benefits of PRT in this cohort. Verf.-Referat